Medical Advocates

Enfuvirtide
[T-20] (Fuzeon)
 
Conference Citations

14th CROI
8th Int Congress on Drug Therapy in HIV Infection

46th ICAAC

XVI International AIDS Conference

13th CROI

45th ICAAC

3rd IAS Conference
6th Int Wkshp on Clinical Pharmacology of HIV Therapy

12th CROI

44th ICAAC
XV International AIDS Conference
Conference Archives


Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
Last Update:  February 26, 2008

14th Conference on Retroviruses and
Opportunistic Infections

  • CONFERENCE PDF POSTER
    Enfuvirtide Does Not Require Dose-adjustment in Patients with Chronic Renal Failure: The Results
    of a Pharmacokinetic Study of Enfuvirtide in HIV-1-infected Patients with Impaired Renal Function
    (NP17586)

    P Tebas, N Bellos, C Lucasti, et al

    PDF Poster    Abstract
  • CONFERENCE PDF POSTER
    Lack of Placental Transfer of Enfuvirtide in an ex vivo Human Placental Cotyledon Perfusion Model
    Ferreira, P Ceccaldi, B Visseaux, et al
    PDF Poster    Abstract
  • CONFERENCE PDF POSTER
    CCR5 Density Levels on Primary CD4 T Cells Affect the Replication and Enfuvirtide Susceptibility of
    R5 HIV-1: Clinical Implications

    A Heredia, B Gilliam, O Latinovic, et al
    PDF Poster    Abstract
  • CONFERENCE PDF POSTER
    Kinetics of Disappearance of Enfuvirtide-resistance HIV-1 Mutations after Drug Discontinuation
    C Charpentier, M Jenabian, C Piketty, et al
    PDF Poster
        Abstract

8th Int Congress on Drug Therapy in HIV Infection
 


XVI International AIDS Conference
 


13th Conference on Retroviruses and
Opportunistic Infections